CJC 1295 no DAC meaning explained: it's a short-acting GHRH analog also called MOD GRF 1-29. Learn how it differs from DAC versions and safety facts.
CJC 1295 no DAC meaning refers to a modified growth hormone-releasing hormone (GHRH) analog that does not contain the Drug Affinity Complex (DAC). Without DAC, the peptide is cleared from the body much faster than standard CJC-1295, with a half-life of roughly 30 minutes. This shorter-acting version is also known as MOD GRF 1-29 or modified GRF(1-29).
What "No DAC" Means in CJC-1295
The cjc-1295 no dac meaning is straightforward: it is a CJC-1295 peptide that lacks the Drug Affinity Complex. DAC is a chemical modification that lets a peptide bind to albumin in the bloodstream, which slows clearance and stretches its half-life. Without DAC, the peptide is cleared much faster.
The practical result is a short, pulsatile release pattern. Researchers who want a quick peak and rapid clearance often choose the no-DAC form. Those who want long, steady exposure may study the DAC version instead.
- With DAC: long half-life, albumin-bound, less frequent dosing in research.
- Without DAC: short half-life, not albumin-bound, more frequent dosing in research.
- Common name for no DAC: MOD GRF 1-29 or modified GRF(1-29).
CJC-1295 No DAC vs CJC-1295 With DAC
The two forms differ mainly in duration of action. CJC-1295 with DAC remains active for days, while CJC-1295 no DAC remains active for less than an hour. That difference shapes how each peptide is studied and discussed.
| Feature | CJC-1295 with DAC | CJC-1295 no DAC (MOD GRF 1-29) |
|---|---|---|
| Half-life | About 6 to 8 days | About 30 minutes |
| Albumin binding | Yes | No |
| Typical research dosing | Less frequent | More frequent |
| Also known as | CJC-1295 DAC | MOD GRF 1-29 |
| FDA-approved for human use | No | No |
The table shows why the two are not interchangeable in research settings. A once-weekly protocol with the DAC version looks very different from a multiple-times-per-day protocol with the no-DAC version. Many comparisons online, such as cjc-1295 dac vs no dac, focus on these timing differences.
Why It's Also Called MOD GRF 1-29
CJC-1295 no DAC is a modified version of growth hormone-releasing factor (GRF), specifically the first 29 amino acids. Scientists added four substitutions to make it more stable than natural GRF(1-29). That is why the peptide appears in research catalogs as cjc-1295 no dac; mod grf 1-29.
The "1-29" refers to the sequence length. Natural GRF is 44 amino acids long, but the first 29 are enough for biological activity. The four substitutions increase stability without changing the core function.
The names are not perfectly standardized. Some vendors list it as modified GRF(1-29), others as CJC-1295 without DAC, and still others as MOD GRF 1-29. They all describe the same short-acting GHRH analog.
How CJC-1295 No DAC Is Studied and Discussed
In laboratory research, CJC-1295 no DAC is often combined with a growth hormone-releasing peptide such as ipamorelin. The idea is to stimulate growth hormone release through two different pathways. Most of this work is preclinical and does not prove benefits in humans.
There is no FDA-approved cjc-1295 no dac dosage for humans because the peptide is not approved for human use. Any dosing information found online comes from anecdotal reports or research protocols, not from controlled clinical trials.
Community discussions often appear on forums and social media. For example, threads like cjc 1295 no dac ipamorelin reddit reflect personal experiences, but they are not medical evidence.
Safety and Legal Status in the United States
CJC-1295 no DAC is not FDA-approved for human use in the United States. It is sold as a research chemical, which means it is not regulated for purity, dosage, or safety in humans. Buying or using it outside of research settings carries legal and health risks.
Potential side effects reported anecdotally include injection-site reactions, headaches, and changes in blood sugar or hormone levels. These reports are not a substitute for clinical data. Anyone considering peptides for health reasons should talk with a licensed healthcare professional first.
Neither CJC-1295 no DAC nor CJC-1295 with DAC is approved by the FDA for human use.
Frequently Asked Questions
What does CJC-1295 no DAC mean?
CJC-1295 no DAC means the peptide does not have the Drug Affinity Complex, a modification that extends half-life by binding to albumin. Without DAC, the peptide is cleared quickly and is also called MOD GRF 1-29.
Is CJC-1295 no DAC the same as MOD GRF 1-29?
Yes, CJC-1295 no DAC and MOD GRF 1-29 are two names for the same modified GHRH analog. Both refer to a short-acting peptide with four amino acid substitutions that increase stability.
Is CJC-1295 no DAC FDA approved?
No, CJC-1295 no DAC is not FDA-approved for human use in the United States. It is sold as a research chemical and should not be used without medical supervision.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.